Pharsight

1. Skyclarys patents expiration

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US9670147	REATA PHARMS	Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17	Apr, 2029 (5 years from now)
US8124799	REATA PHARMS	Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17	Dec, 2029 (6 years from now)
US8993640	REATA PHARMS	2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof	Apr, 2033 (9 years from now)
US9701709	REATA PHARMS	2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof	Apr, 2033 (9 years from now)
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8440854	REATA PHARMS	Antioxidant inflammation modulators: oleanolic acid derivatives with amino acid and other modifications at C-17	Apr, 2029 (5 years from now)
US11091430	REATA PHARMS	Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17	Apr, 2029 (5 years from now)